CTA
CVS icon

Chesley Taft & Associates’s CVS Health CVS Stock Holding History

Chesley Taft & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Buy
+1,989
New +$178K 0.01% 366
2024
Q2 		– Sell
-7,462
Closed -$595K – 312
2024
Q1 		$595K Sell
7,462
-27,240
-78% -$2.08M 0.03% 228
2023
Q4 		$2.74M Sell
34,702
-7,775
-18% -$553K 0.15% 111
2023
Q3 		$2.97M Sell
42,477
-111,805
-72% -$7.92M 0.19% 106
2023
Q2 		$10.7M Sell
154,282
-9,520
-6% -$677K 0.65% 44
2023
Q1 		$12.2M Buy
163,802
+30,783
+23% +$2.58M 0.8% 37
2022
Q4 		$12.4M Buy
133,019
+92,822
+231% +$8.96M 0.85% 34
2022
Q3 		$3.83M Buy
40,197
+1,120
+3% +$111K 0.28% 84
2022
Q2 		$3.62M Buy
39,077
+344
+0.9% +$33.6K 0.25% 92
2022
Q1 		$4.05M Buy
38,733
+29,188
+306% +$3.07M 0.24% 90
2021
Q4 		$985K Hold
9,545
– – 0.05% 183
2021
Q3 		$810K Buy
9,545
+200
+2% +$16.8K 0.05% 195
2021
Q2 		$780K Hold
9,345
– – 0.04% 195
2021
Q1 		$701K Hold
9,345
– – 0.04% 195
2020
Q4 		$638K Buy
9,345
+2,125
+29% +$138K 0.04% 194
2020
Q3 		$422K Buy
7,220
+350
+5% +$21.8K 0.03% 211
2020
Q2 		$446K Buy
6,870
+2,707
+65% +$170K 0.03% 198
2020
Q1 		$247K Buy
4,163
+367
+10% +$24.5K 0.02% 229
2019
Q4 		$282K Hold
3,796
– – 0.02% 246
2019
Q3 		$239K Buy
3,796
+37
+1% +$2.19K 0.02% 249
2019
Q2 		$205K Sell
3,759
-1,410
-27% -$75.9K 0.02% 247
2019
Q1 		$279K Sell
5,169
-98,959
-95% -$6.11M 0.02% 232
2018
Q4 		$6.82M Buy
104,128
+99,384
+2,095% +$7.42M 0.66% 50
2018
Q3 		$373K Buy
4,744
+601
+15% +$43K 0.03% 237
2018
Q2 		$267K Buy
4,143
+301
+8% +$19.8K 0.02% 250
2018
Q1 		$239K Sell
3,842
-59
-2% -$4.23K 0.02% 253
2017
Q4 		$283K Sell
3,901
-6,999
-64% -$509K 0.02% 257
2017
Q3 		$886K Buy
10,900
+1
+0% +$79 0.08% 178
2017
Q2 		$877K Hold
10,899
– – 0.08% 182
2017
Q1 		$856K Sell
10,899
-11,514
-51% -$919K 0.08% 185
2016
Q4 		$1.77M Sell
22,413
-102,639
-82% -$8.31M 0.17% 112
2016
Q3 		$11.1M Buy
125,052
+1,805
+1% +$170K 1.12% 33
2016
Q2 		$11.8M Buy
123,247
+326
+0.3% +$32.5K 1.21% 27
2016
Q1 		$12.8M Buy
122,921
+2,875
+2% +$280K 1.34% 21
2015
Q4 		$11.7M Sell
120,046
-10,115
-8% -$991K 1.23% 20
2015
Q3 		$12.6M Buy
130,161
+851
+0.7% +$89.5K 1.37% 20
2015
Q2 		$13.6M Buy
129,310
+2,175
+2% +$222K 1.38% 23
2015
Q1 		$13.1M Buy
127,135
+257
+0.2% +$26K 1.35% 22
2014
Q4 		$12.2M Buy
126,878
+1,400
+1% +$123K 1.24% 26
2014
Q3 		$9.99M Buy
125,478
+15,060
+14% +$1.19M 1.05% 35
2014
Q2 		$8.32M Buy
110,418
+2,130
+2% +$161K 0.86% 42
2014
Q1 		$8.11M Buy
108,288
+39,750
+58% +$2.81M 0.87% 44
2013
Q4 		$4.91M Buy
68,538
+8,581
+14% +$551K 0.49% 73
2013
Q3 		$3.4M Buy
59,957
+40,650
+211% +$2.42M 0.37% 80
2013
Q2 		$1.1M Buy
+19,307
New +$1.12M 0.13% 144

Other funds holding CVS

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Chesley Taft & Associates's CVS Position: Q2 2026 in Review

Chesley Taft & Associates opened a new position in CVS Health (CVS) in Q2 2026: 1,989 shares worth $206K. The stake represents 0.01% of the portfolio and ranks #366 among its holdings. This is a return to the name: Chesley Taft & Associates previously reported a position in CVS as recently as Q1 2024.

Chesley Taft & Associates first reported a position in CVS in Q2 2013 and has held it in 45 quarters since. The position peaked at $13.6M in Q2 2015. 886 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Chesley Taft & Associates held 1,989 shares of CVS Health worth $206K as of Q2 2026.
  • CVS Health was a new Chesley Taft & Associates position in Q2 2026.
  • CVS Health made up 0.01% of Chesley Taft & Associates's portfolio in Q2 2026, its #366 holding.
  • Chesley Taft & Associates first reported a position in CVS Health in Q2 2013 and has held it in 45 quarters since.
  • Chesley Taft & Associates's CVS Health position peaked at $13.6M in Q2 2015.
  • 886 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Chesley Taft & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.